(MTX) MTU Aero Engines - Overview
Stock: Commercial Engines, Military Engines, Gas Turbines, Engine MRO, Spare Parts
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.68% |
| Yield on Cost 5y | 1.14% |
| Yield CAGR 5y | 15.18% |
| Payout Consistency | 94.3% |
| Payout Ratio | 16.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.5% |
| Relative Tail Risk | -5.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | 10.12 |
| Character TTM | |
|---|---|
| Beta | 0.257 |
| Beta Downside | 0.583 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.13% |
| CAGR/Max DD | 0.58 |
Description: MTX MTU Aero Engines December 19, 2025
MTU Aero Engines AG (XETRA:MTX) designs, produces, markets, and services both commercial and military aircraft engines as well as aero-derivative gas turbines. Its operations are split between an Original Equipment Manufacturing (OEM) segment and a Maintenance, Repair & Overhaul (MRO) segment, covering a product range that spans wide-body, narrow-body, regional and business-jet engines, fighter-jet and helicopter powerplants, and industrial turbines.
Key recent metrics: FY 2023 revenue reached €13.2 bn, with an adjusted EBIT margin of roughly 9 %, reflecting strong demand in the commercial OEM market and a resilient MRO backlog of €7.5 bn. The company’s exposure to the CFM LEAP engine program-jointly owned with Safran-drives a significant portion of its order intake, while rising defense budgets in Europe and the U.S. underpin its military-engine segment. Fuel-price volatility and the pace of airline capacity restoration remain material macro-drivers of earnings.
For a deeper quantitative view of MTX’s valuation and risk profile, consider reviewing the data available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 1.35b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.69 > 1.0 |
| NWC/Revenue: 15.69% < 20% (prev 12.01%; Δ 3.68% < -1%) |
| CFO/TA 0.07 > 3% & CFO 778.0m > Net Income 1.35b |
| Net Debt (1.18b) to EBITDA (2.09b): 0.56 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.3m) vs 12m ago -3.94% < -2% |
| Gross Margin: 19.06% > 18% (prev -0.04%; Δ 1910 % > 0.5%) |
| Asset Turnover: 107.3% > 50% (prev 71.82%; Δ 35.51% > 0%) |
| Interest Coverage Ratio: 14.0 > 6 (EBITDA TTM 2.09b / Interest Expense TTM 119.0m) |
Altman Z'' 3.48
| A: 0.16 (Total Current Assets 6.79b - Total Current Liabilities 4.88b) / Total Assets 11.78b |
| B: 0.28 (Retained Earnings 3.32b / Total Assets 11.78b) |
| C: 0.15 (EBIT TTM 1.67b / Avg Total Assets 11.37b) |
| D: 0.49 (Book Value of Equity 3.85b / Total Liabilities 7.87b) |
| Altman-Z'' Score: 3.48 = A |
Beneish M -2.89
| DSRI: 0.66 (Receivables 2.64b/2.57b, Revenue 12.20b/7.87b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.95 (AQ_t 0.27 / AQ_t-1 0.28) |
| SGI: 1.55 (Revenue 12.20b / 7.87b) |
| TATA: 0.05 (NI 1.35b - CFO 778.0m) / TA 11.78b) |
| Beneish M-Score: -2.89 (Cap -4..+1) = A |
What is the price of MTX shares?
Over the past week, the price has changed by +1.01%, over one month by -2.69%, over three months by +3.12% and over the past year by +15.94%.
Is MTX a buy, sell or hold?
What are the forecasts/targets for the MTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 419 | 10.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 438.2 | 15.2% |
MTX Fundamental Data Overview February 03, 2026
P/E Trailing = 24.1457
P/E Forward = 20.8768
P/S = 2.3826
P/B = 5.2064
P/EG = 1.3382
Revenue TTM = 12.20b EUR
EBIT TTM = 1.67b EUR
EBITDA TTM = 2.09b EUR
Long Term Debt = 1.97b EUR (from longTermDebt, last quarter)
Short Term Debt = 288.0m EUR (from shortTermDebt, last quarter)
Debt = 2.45b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.18b EUR (from netDebt column, last quarter)
Enterprise Value = 21.32b EUR (20.14b + Debt 2.45b - CCE 1.27b)
Interest Coverage Ratio = 14.0 (Ebit TTM 1.67b / Interest Expense TTM 119.0m)
EV/FCF = 61.98x (Enterprise Value 21.32b / FCF TTM 344.0m)
FCF Yield = 1.61% (FCF TTM 344.0m / Enterprise Value 21.32b)
FCF Margin = 2.82% (FCF TTM 344.0m / Revenue TTM 12.20b)
Net Margin = 11.06% (Net Income TTM 1.35b / Revenue TTM 12.20b)
Gross Margin = 19.06% ((Revenue TTM 12.20b - Cost of Revenue TTM 9.88b) / Revenue TTM)
Gross Margin QoQ = 22.39% (prev 17.53%)
Tobins Q-Ratio = 1.81 (Enterprise Value 21.32b / Total Assets 11.78b)
Interest Expense / Debt = 3.35% (Interest Expense 82.0m / Debt 2.45b)
Taxrate = 29.41% (240.0m / 816.0m)
NOPAT = 1.18b (EBIT 1.67b * (1 - 29.41%))
Current Ratio = 1.39 (Total Current Assets 6.79b / Total Current Liabilities 4.88b)
Debt / Equity = 0.64 (Debt 2.45b / totalStockholderEquity, last quarter 3.84b)
Debt / EBITDA = 0.56 (Net Debt 1.18b / EBITDA 2.09b)
Debt / FCF = 3.42 (Net Debt 1.18b / FCF TTM 344.0m)
Total Stockholder Equity = 3.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.87% (Net Income 1.35b / Total Assets 11.78b)
RoE = 37.87% (Net Income TTM 1.35b / Total Stockholder Equity 3.56b)
RoCE = 30.11% (EBIT 1.67b / Capital Employed (Equity 3.56b + L.T.Debt 1.97b))
RoIC = 21.13% (NOPAT 1.18b / Invested Capital 5.56b)
WACC = 6.37% (E(20.14b)/V(22.59b) * Re(6.86%) + D(2.45b)/V(22.59b) * Rd(3.35%) * (1-Tc(0.29)))
Discount Rate = 6.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.53%
[DCF Debug] Terminal Value 85.28% ; FCFF base≈408.4m ; Y1≈443.7m ; Y5≈554.6m
Fair Price DCF = 241.2 (EV 14.15b - Net Debt 1.18b = Equity 12.97b / Shares 53.8m; r=6.37% [WACC]; 5y FCF grow 9.84% → 2.90% )
EPS Correlation: 85.38 | EPS CAGR: 65.78% | SUE: 0.51 | # QB: 0
Revenue Correlation: 44.24 | Revenue CAGR: 46.21% | SUE: 2.32 | # QB: 1
EPS next Year (2026-12-31): EPS=18.90 | Chg30d=+0.023 | Revisions Net=+0 | Growth EPS=+6.0% | Growth Revenue=+9.2%